MK-801-induced neuronal damage in rats

Brain Research

Volumn 753, Issue 2, 1997, Pages 181-195

  Horváth, Zsolt C ^a   Czopf, János ^a,b   Buzsáki, György ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Neurophysiol Res Grp of the H   (Hungary)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

entorhinal cortex; hippocampus; MK 801; neuronal degeneration; NMDA; pyriform cortex; retrosplenial cortex

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MICROGLIA; NEURONS; RATS; RATS, WISTAR; SILVER; STAINING AND LABELING; TIME FACTORS;

EID: 0031564609     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01290-5     Document Type: Article

References (55)

1. Aitken, P.G., Balestrino, M. and Somjen, G.G., NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices, Neurosci. Lett., 89 (1988) 187-192.
2. Allen, H.L. and Iversen, L.L., Phencyclidine, dizocilpine, and cerebrocortical neurons (Technical comments), Science, 247 (1990) 221.
3. Beltramino, C.A., de Olmos, J.S., Gallyas, F., Heimer, L. and Záborszky, L., Silver staining as a tool for neurotoxic assessment, NIDA. Res. Monogr., 136 (1993) 101-126.
4. Clineschmidt, B.V., Martin, G.E. and Bunting, P.R., Anticonvulsant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties, Drug Dev. Res., 2 (1982) 123.
5. Collingridge, G.L. and Bliss, T.V.P., NMDA receptors - their role in long-term potentiation, Trends Neurosci., 10 (1987) 288-293.
6. Collingridge, G.L., Coan, E.J., Herron, C.E. and Lester, R.A.J., T.P. Hicks, D. Lodge and H. McLennan (Eds.) Excitatory Amino Acid Transmission, Alan R. Liss, 1987, pp. 317-324.
7. Collingridge, G.L. and Lester, R.A.J., Excitatory amino acid receptors in the vertebrate central nervous system, Pharmacol. Rev., 40 (1989) 143-210.
8. Collins, R.C. and Olney, J.W., Focal cortical seizures cause distant thalamic lesions, Science, 218 (1982) 177-179.
9. Coppel, D.L., Bovill, J.G. and Dundee, J.W., The taming of ketamine, Anaesthesia, 28 (1973) 293-296.
10. Cotman, C.W. and Iversen, L.L., Excitatory amino acids in the brain-focus on NMDA receptors, Trends Neurosci., 10 (1987) 263-265.
11. Dirnagl, U., Tanabe, J. and Pulsinelli, W., Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat, Brain. Res., 527 (1990) 62-68.
12. Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, C., A., Long, G.G., Storts, R.W., Farber, N., Wozniak, D.F. and Olney, J.W., Neuronal vacualization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (Dizocilpine Maleate): A light and electronmicroscopic evaluation of the rat retrosplenial cortex, Exp. Neurol., 123 (1993) 204-215.
13. Foster, A.C., Gill, R., Kemp, J.A. and Woodruff, G.N., Systemic administration of MK-801 prevents NMDA-induced neuronal degeneration in the rat brain, Neurosci. Lett., 76 (1987) 307-311.
14. Foster, A.C. and Wong, E.H.F., The novel anticonvulsant MK-801 binds to the activated state of the NMDA receptor in rat brain, Br. J. Pharmacol., 91 (1987) 403-409.
15. Gallyas, F., Silver staining of micro- and oligodendroglia by means of physical development, Acta Neuropathol., 16 (1970) 35-38.
16. Gallyas, F., Guldner, F.H., Zoltay, G. and Wolff, J.R., Golgi-like demonstration of 'dark' neurons with an argyrophil III method for experimental neuropathology, Acta Neuropathol. (Berl.), 79 (1990) 620-628.
17. Gallyas, F., Hsu, M. and Buzsáki, G., Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: 'dark' neurons, perikarya of all neurons, microglial cells and capillaries, J. Neurosci. Methods, 50 (1993) 159-164.
18. Gallyas, F., Zoltay, G., Horváth, Z., Dávid, K. and Kellényi, L., An immediate morphopathologic response of neurons to electroshock; a reliable model for producing 'dark' neurons in experimental neuropathology, Neurobiology, 1 (1993) 133-146.
19. Gill, R., Foster, A.C. and Woodruff, G.N., Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil, J. Neurosci., 7 (1987) 3343-3349.
20. Gill, R., Foster, A.C. and Woodruff, G.N., MK-801 is neuroprotective in gerbils when administered during the post-ischemic period, Neuroscience, 25 (1988) 847-855.
21. Horváth, Z. and Buzsáki, G., MK-801-induced neuronal degeneration in normal rats, Soc. Neurosci. Abstr., 19 (1993) 354.
22. Hsu, M. and Buzsáki, G., Vulnerability of mossy fiber targets in the rat hippocampus to forbrain ischemia, J. Neurosci., 13 (1993) 3964-3979.
23. Kemp, J.A., Foster, A.C. and Wong, E.H.F., Non-competitive antagonists of excitatory amino acid receptors, Trends Neurosci., 10 (1987) 294-298.
24. Li, X., Somogyi, P., Ylinen, A. and Buzsáki, G., The hippocampal CA3 network: an in vivo intracellular labelling study, J. Comp. Neurol., 339 (1994) 181-208.
25. Lyden, P.D. and Hedges, B., Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits, Stroke, 23 (1992) 1463-1469.
26. McDonald, J.W., Silverstein, F.S. and Johnston, M.V., MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats, Neuroscience, 38 (1990) 103-113.
27. Miettinen, R., Lahtinen, H., Riekkinen, P.J., Freund, T.F., Hsu, M., Horváth, Z. and Buzsáki, G., Persistent axonal degeneration in the hippocampus after transection of the fimbria-fornix, Restor. Neurol. Neurosci., (1993) 1-9.
28. Mody, I. and Heinemann, U., NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling, Nature, 326 (1987) 701-704.
29. Morris, R.G.M., Anderson, E., Lynch, G.S. and Baudry, M., Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5, Nature, 319 (1986) 774-776.
30. Murase, K., Kato, H. and Kogure, K., Limited but evident protective effects of MK-801 and pentobarbital on neuronal damage following forebrain ischemia in the gerbil under normothermic conditions, Neurosci. Lett., 149 (1993) 229-232.
31. Olney, J.W., Labruyere, J. and Price, M.T., Phencyclidine, dizocilpine, and cerebrocortical neurons (technical comments), Science, 247 (1990) 221.
32. Olney, J.W., Labruyere, J. and Price, M.T., Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science, 244 (1989) 1360-1362.
33. Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: Mechanism and prevention, Science, 254 (1991) 1515-1518.
34. Palmer, G.C., Haris, E.W., Ray, R., Stagnitto, M.L. and Schmiesing, R.J., Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro, Arch. Int. Pharmacodyn. Ther., 317 (1992) 16-34.
35. Pavlides, C., Magarinos, A., Gould, E., Hsu, M., Pierre, E., Watanabe, Y., McEwen, B.S. and Buzsáki, G., Adrenalectomy-induced degeneration of granule cells but not CA3 interneurons is prevented by corticosterone treatment, Soc. Neurosci. Abstr., 19 (1993) 168.
36. Pechnick, R.N., George, R. and Poland, R.E., Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat, Eur. J. Pharmacol., 164 (1989) 257-263.
37. Peeters, B.W. and Vanderheyden, P.M., In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site, Epilepsy Res., 12 (1992) 157-162.
38. Reich, D.L. and Silvay, G., Ketamine: an update on the first twenty-five years of clinical experience, Can. J. Anaesth., 36 (1989) 186-197.
39. Rothman, S., Synaptic release of excitatory amino acid neurotrasmitter mediates anoxic neuronal death, J. Neurosci., 4 (1984) 1884-1891.
40. Rothman, S.M. and Olney, J.W., Excitotoxicity and the NMDA receptor, Trends Neurosci., 10 (1987) 299-302.
41. Rothman, S.M. and Olney, J.W., Excitotoxicity and the NMDA receptor-still lethal after eight years, Trends Neurosci, 18 (1995) 57-58.
42. Santiago, M., Venero, J.L., Machado, A. and Cano, J., In vitro pro-D-aspartate antagonists, Brain Res., 586 (1992) 203-207.
43. Schwartz, P.H. and Wasterlain, C.G., Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the rat, Res. Commun. Chem. Pathol. Pharmacol., 73 (1991) 181-195.
44. Seress, L. and Pokorny, J., Structure of the granular layer of the rat dentate gyrus. A light microscopic and Golgi study, J. Anat., 133 (1981) 181-195.
45. Siegel, S., Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill Book Company, Inc., New York, Toronto, London, 1956.
46. Sloviter, R.S., 'Epileptic' brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies, Brain. Res. Bull., 10 (1983) 675-697.
47. Somjen, G.G., Basic mechanisms in cerebral hypoxia and stroke: Background, review and conclusions. In G.G. Somjen (Ed.), Mechanisms of Cerebral Hypoxia and Stroke, Plenum Publishing Corporation, 1988, pp. 447-466.
48. 2+] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-D-aspartate, Epilepsy Res., 1 (1987) 53-62.
49. Stein-Behrens, B., Mattson, M., Chang, I., Yeh, M. and Sapolsky, R., Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus, J. Neurosci., 14 (1994) 5373-5380.
50. van den Pol, A.N. and Gallyas, F., Trauma-induced Golgi-like staining of neurons: a new approach to neuronal organization and response to injury, J. Comp. Neurol., 296 (1990) 654-673.
51. Vezzani, A., Serafini, R., Stasi, M.A., Caccia, S., Conti, I., Tridico, R.V. and Samanin, R., Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats, J. Pharmacol. Exp. Ther., 249 (1989) 278-283.
52. Watkins, J.C. and Olverman, H.J., Agonists and antagonists for excitatory amino acid receptors, Trends Neurosci., 10 (1987) 265-272.
53. Wieloch, T., Hypoglycaemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist, Science, 230 (1985) 681-683.
54. Williamson, J.M. and Lothman, E.W., The effect of MK-801 on kindled seizures: Implocations for use and limitations as an antiepileptic drug, Ann. Neurol., 26 (1989) 85-90.
55. Wong, E.H.F., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N. and Iverson, L.L., The anticonvulsant MK-801 is a potent NMDA antagonist, Proc. Natl. Acad. Sci. USA, 83 (1986) 7104-7108.